EX-32.2 6 w11762exv32w2.htm EX-32.2 exv32w2
 

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     In connection with the Quarterly Report of Novavax, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dennis W. Genge, Vice-President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
  1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
  By:   /s/ Dennis W. Genge    
  Name:   Dennis W. Genge   
  Title:   Vice President and
Chief Financial Officer
 
 
  August 9, 2005   
 

34